SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-24-030458
Filing Date
2024-03-04
Accepted
2024-03-04 15:51:59
Documents
14
Period of Report
2024-03-04
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm247844d3_8k.htm   iXBRL 8-K 25697
  Complete submission text file 0001104659-24-030458.txt   196460

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA avdl-20240304.xsd EX-101.SCH 3067
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE avdl-20240304_lab.xml EX-101.LAB 34240
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE avdl-20240304_pre.xml EX-101.PRE 22355
15 EXTRACTED XBRL INSTANCE DOCUMENT tm247844d3_8k_htm.xml XML 3485
Mailing Address 16640 CHESTERFIELD GROVE ROAD SUITE 200 CHESTERFIELD MO 63005
Business Address BLOCK 10-1 BLANCHARDSTOWN CORPORATE PARK BALLYCOOLIN DUBLIN L2 15 636-449-1830
AVADEL PHARMACEUTICALS PLC (Filer) CIK: 0001012477 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37977 | Film No.: 24714841
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)